Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada
Authors: Michelle Le, Feras M. Ghazawi, Akram Alakel, Elena Netchiporouk, Elham Rahme, Andrei Zubarev, Mathieu Powell, Linda Moreau, Osama Roshdy, Steven J. Glassman, Denis Sasseville, Gizelle Popradi, and Ivan V. Litvinov
Background Follicular lymphoma (FL) is the most common indolent lymphoma and the 2nd most common non- Hodgkin lymphoma, accounting for 10%-20% of all lymphomas in the Western world. Epidemiologic and geographic trends of FL in Canada have not been investigated. Our study’s objective was to analyze incidence and mortality rates and the geographic distribution of FL patients in Canada for 1992-2010. Methods Demographic and geographic patient data for FL cases were obtained using the Canadian Cancer Registry, the Registre quebecois du cancer, and the Canadian Vital Statistics database. Incidence and mortality rates and 95% confidence intervals were calculated per year and per geographic area. Rates were plotted using linear regression models to assess trends over time. Overall data were mapped using Microsoft Excel mapping software (Redmond, WA, U.S.A.) to identify case clusters across Canada. Results Approximately 22,625 patients were diagnosed with FL during 1992-2010. The age-standardized incidence rate of this malignancy in Canada was 38.3 cases per million individuals per year. Geographic analysis demonstrated that a number of Maritime provinces and Manitoba had the highest incidence rates, and that the provinces of Nova Scotia and Quebec had the highest mortality rates in the nation. Regional data demonstrated clustering of FL within cities or regions with high herbicide use, primary mining, and a strong manufacturing presence. Conclusions Our study provides a comprehensive overview of the FL burden and its geographic distribution in Canada. Regional clustering of this disease in concentrated industrial zones strongly suggests that multiple environmental factors might play a crucial role in the development of this lymphoma.
Please note that abstracts only appear in the language of the publication and might not have a translation.
Y. Yuan, J. Ross, Q. Shi, and F. G. Davis (2017).
Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000-2008
Current Oncology , 341-347
Emily V. Walker, J. Ross, Y. Yuan, T. R. Smith, and F. G. Davis (2019).
Brain cancer survival in Canada 1996-2008: Effects of sociodemographic characteristics
Current Oncology , 292-299
A. Blair, L. Gauvin, S. Ouédraogo, and G. Datta. (2019).
Area-level income and colorectal cancer screening among urban-dwelling Canadians: Evidence to guide future surveillance
Current Oncology , 128-137
A. C. Coronado, C. Finley, K. Badovinac, J. Han, J. Niu, and R. Rahal (2018).
Discrepancies between Canadian cancer research funding and site-specific cancer burden
Current Oncology , 338-341
Liu, Jiaqi L., Walker, Emily V., Paudel, Yuba Raj, Davis, Faith G., and Yuan, Yan (2022).
Brain Metastases among Cancer Patients Diagnosed from 2010–2017 in Canada: Incidence Proportion at Diagnosis and Estimated Lifetime Incidence
Current Oncology , 2091-2105
Laetitia Amar, Michelle Le, Feras M. Ghazawi, Elham Rahme, Amanda Segal, Elena Netchiporouk, Gizelle Popradi, Linda Moreau, Osama Roshdy, Denis Sasseville, and Ivan Litvinov (2019).
Prevalence of human T cell lymphotropic virus 1 infection in Canada
Current Oncology , e3-e5
J. Tung, C. E. Politis, J. Chadder, J. Han, J. Niu, S. Fung, R. Rahal, and C. C. Earle (2018).
The north-south and east-west gradient in colorectal cancer risk: A look at the distribution of modifiable risk factors and incidence across Canada
Current Oncology , 231-235
Simon F. Roy, Feras M. Ghazawi, Michelle Le, François Lagacé, Catherine F. Roy, Elham Rahme, Evgeny Savin, Andrei Zubarev, Denis Sasseville, Gizelle Popradi, and Ivan V. Litvinov (2020).
Epidemiology of adult and pediatric Burkitt Lymphoma in Canada: Sequelae of the HIV epidemic
Current Oncology , 83-89